Floatz logo

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

MYC Gene Rearrangement

The First Affiliated Hospital with Nanjing Medical Universitymonoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

6 Active assets in the MYC Gene Rearrangement cohort.

Asset / SponsorPhaseRating
Inno-206
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC
PREDNISONE TABLETS
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC
Cyclophosphamide
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC
(+)-VINCRISTINE
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC
ETOPOSIDE
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC
cc-5013
The First Affiliated Hospital with Nanjing Medical University
Phase 1/2CCC

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant
BBB
Indicative ·
78 / 100
View asset →
Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant
BBB
Indicative ·
76 / 100
View asset →
lymphoblastic lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →